Hybrid Interventions in Congenital Heart Disease
- PMID: 38839172
- DOI: 10.1016/j.iccl.2024.02.005
Hybrid Interventions in Congenital Heart Disease
Abstract
Hybrid interventions in congenital heart disease (CHD) embody the inherent collaboration between congenital interventional cardiology and cardiothoracic surgery. Hybrid approaches to complex and common lesions provide the opportunity to circumvent the limitations of patient size, vascular access, severity of illness, and anatomy that would otherwise be prohibitive to surgical and percutaneous techniques alone. This review describes several important hybrid approaches to interventions in CHD.
Keywords: Aortic stent implantation; Atrial septal defect creation; Congenital heart disease; Congenital interventional cardiology; Hybrid interventions; Hypoplastic left heart syndrome; Transcatheter valve implantation; Ventricular septal defect closure.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Drs A. Salavitabar and S.A. Carrillo have no commercial or financial conflicts of interest nor any funding sources. Dr A.K. Armstrong is a consultation for Abbott, Edwards Lifesciences, Medtronic Inc., Cook Medical, Starlight Cardiovascular, and B.Braun Interventional Systems Inc. Dr A.K. Armstrong receives research support for Edwards Lifesciences, United States, Renata Medical, and atHeart Medical LLC.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
